All Stories

  1. Impact of RAS-MAPK Pathway Genetic Alterations on Radiotherapy Response in Metastatic Lung Adenocarcinoma
  2. Integration of Next Generation Sequencing Data to Inform Survival Prediction of Patients with Spine Metastasis
  3. Role of Minimally Invasive Spine Surgery in Spine Oncology
  4. Frontline Voice: AO Spine Member Survey Regarding Spine Oncology Knowledge Generation and Translation Needs
  5. Overview of Molecular Prognostication for Common Solid Tumor Histologies – What the Surgeon Should Know
  6. Robotic Resection of Spinal and Paraspinal Tumors
  7. Patient-Reported and Clinical Outcomes of Surgically Treated Patients With Symptomatic Spinal Metastases: Results From Epidemiology, Process, and Outcomes of Spine Oncology (EPOSO), a Prospective, Multi-Institutional and International Study
  8. Long-Term Clinical Outcomes of Patients with Colorectal Cancer with Metastatic Epidural Spinal Cord Compression Treated with Hybrid Therapy (Surgery Followed by Stereotactic Body Radiation Therapy)
  9. The Impact of Targetable Mutations on Clinical Outcomes of Metastatic Epidural Spinal Cord Compression in Patients With Non–Small-Cell Lung Cancer Treated With Hybrid Therapy (Surgery Followed by Stereotactic Body Radiation Therapy)
  10. Clinical reliability of genomic data obtained from spinal metastatic tumor samples
  11. Improvement in Quality of Life Following Surgical Resection of Benign Intradural Extramedullary Tumors: A Prospective Evaluation of Patient-Reported Outcomes
  12. Robotic Resection of a Nerve Sheath Tumor Via a Retroperitoneal Approach
  13. Survival Trends After Surgery for Spinal Metastatic Tumors: 20-Year Cancer Center Experience
  14. The Role of Minimal Access Surgery in the Treatment of Spinal Metastatic Tumors
  15. Association of neurologic deficits with surgical outcomes and health‐related quality of life after treatment for metastatic epidural spinal cord compression
  16. Image guidance in spine tumor surgery
  17. Essential Concepts for the Management of Metastatic Spine Disease: What the Surgeon Should Know and Practice
  18. Survival, local control, and health-related quality of life in patients with oligometastatic and polymetastatic spinal tumors: A multicenter, international study
  19. Minimal Access Surgery for Spinal Metastases: Prospective Evaluation of a Treatment Algorithm Using Patient Reported Outcomes
  20. Current Role of Uninstrumented Lumbar Fusion
  21. State of the Art Treatment of Spinal Metastatic Disease
  22. Patient-reported outcomes after surgical stabilization of spinal tumors: symptom-based validation of the Spinal Instability Neoplastic Score (SINS) and surgery
  23. Safety and utility of kyphoplasty prior to spine stereotactic radiosurgery for metastatic tumors: a clinical and dosimetric analysis
  24. Predictors of quality of life improvement after surgery for metastatic tumors of the spine: prospective cohort study
  25. Validation of Spinal Instability Neoplastic Score Components through Patient-Reported Outcomes
  26. 178 Hybrid Surgery-Radiosurgery Therapy for Metastatic Epidural Spinal Cord Compression (MESCC): A Prospective Evaluation Using Patient-Reported Outcomes
  27. Continuous mapping of the corticospinal tracts in intramedullary spinal cord tumor surgery using an electrified ultrasonic aspirator
  28. Hybrid surgery–radiosurgery therapy for metastatic epidural spinal cord compression: A prospective evaluation using patient-reported outcomes
  29. Integrating Evidence-Based Medicine for Treatment of Spinal Metastases Into a Decision Framework: Neurologic, Oncologic, Mechanicals Stability, and Systemic Disease
  30. Clinical outcomes following resection of giant spinal schwannomas: a case series of 32 patients
  31. Peripheral nervous system injury after high-dose single-fraction image-guided stereotactic radiosurgery for spine tumors
  32. Letter to the Editor: Evoked potentials and Chiari malformation Type 1
  33. The impact of histology and delivered dose on local control of spinal metastases treated with stereotactic radiosurgery
  34. Pediatric Intradural Spinal Cord Tumors
  35. A non-aggressive, highly efficient, enzymatic method for dissociation of human brain-tumors and brain-tissues to viable single-cells
  36. The value of multimodality intraoperative neurophysiological monitoring in treating pediatric Chiari malformation type I
  37. Novel antiphospholipid antibodies in autoimmune bullous diseases
  38. Erratum to: Infectious Aspects and the Etiopathogenesis of Rheumatoid Arthritis
  39. Intraoperative Seizures During Awake Craniotomy
  40. Failed awake craniotomy: a retrospective analysis in 424 patients undergoing craniotomy for brain tumor
  41. Helicobacter pylori serology in autoimmune diseases – fact or fiction?
  42. Outcome of Elderly Patients Undergoing Awake-Craniotomy for Tumor Resection
  43. Serum markers of infections in patients with primary biliary cirrhosis: evidence of infection burden
  44. Prevalence of anti-toxoplasma antibodies in patients with autoimmune diseases
  45. Medical students' self-report of mental health conditions
  46. Autoimmune bullous diseases
  47. Infectious Serologies and Autoantibodies in Hepatitis C and Autoimmune Disease-Associated Mixed Cryoglobulinemia
  48. Geographical Differences in Autoantibodies and Anti-infectious Agents Antibodies Among Healthy Adults
  49. A comprehensive evaluation of serum autoantibodies in primary biliary cirrhosis
  50. Three-dimensional surface imaging for clinical trials: Improved precision and reproducibility in circumference measurements of thighs and abdomens
  51. Common infectious agents prevalence in antiphospholipid syndrome
  52. Infectious antibodies in systemic lupus erythematosus patients
  53. Anti-infectious Antibodies and Autoimmune-associated Autoantibodies in Patients with Type I Diabetes Mellitus and their Close Family Members
  54. Infections May Have a Protective Role in the Etiopathogenesis of Celiac Disease
  55. Antitreponemal Antibodies Leading to Autoantibody Production and Protection from Atherosclerosis in Kitavans from Papua New Guinea
  56. Autoantibody Screen in Inflammatory Myopathies High Prevalence of Antibodies to Gliadin
  57. Exposure to Epstein-Barr Virus Infection Is Associated with Mild Systemic Lupus Erythematosus Disease
  58. Gluten Sensitivity in Multiple Sclerosis
  59. Infectious Serologies and Autoantibodies in Wegener's Granulomatosis and Other Vasculitides
  60. Infectious Serologies and Autoantibodies in Inflammatory Bowel Disease
  61. The Role of Infections in the Immunopathogensis of Systemic Sclerosis-Evidence from Serological Studies
  62. Infectious Aspects and the Etiopathogenesis of Rheumatoid Arthritis
  63. Prevalence of hepatitis C serum antibody in autoimmune diseases
  64. Infections and autoimmune thyroid diseases: Parallel detection of antibodies against pathogens with proteomic technology
  65. The putative protective role of hepatitis B virus (HBV) infection from autoimmune disorders
  66. Neuropsychiatric lupus and infectious triggers
  67. Viral infection can induce the production of autoantibodies
  68. Novel Insights Into Associations of Antibodies Against Cardiolipin and beta2-glycoprotein I with Clinical Features of Antiphospholipid Syndrome
  69. Epstein Barr Virus and Cytomegalovirus in Autoimmune Diseases: Are They Truly Notorious? A Preliminary Report
  70. Molecular mimicry and auto-immunity
  71. Molecular mimicry and auto-immunity
  72. Reduced placental growth and hCG secretion in vitro induced by antiphospholipid antibodies but not by anti-Ro or anti-La: studies on sera from women with SLE/PAPS
  73. Evaluation of the BioPlex™ 2200 ANA Screen: Analysis of 510 Healthy Subjects: Incidence of Natural/Predictive Autoantibodies